Huntsman (NYSE:HUN) 株価情報

Huntsman

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

Analyst Ratings

この3ヶ月間に4人のアナリストからHuntsman（NYSE:HUN）に対するレーティングが出され、高評価と低評価の両方が見られた。以下の表は、これらのアナリストによる最新の評価をまとめたもので、過去30日間の変化や、それ以前の数ヶ月間の評価との比較も示している。

Huntsmanレーティングへの評価　４人のアナリストが見解

Huntsman Corp

HUITONGDA NETWORK U/ADR by HUITONGDA NETWORK CO LTD.

HUANENG PWR INTL by Huaneng Power International, Inc.

Huaneng Power International Inc

HUNT

HUNTER MARITIME ACQ CRP A by Hunter Maritime Acquisition Corp.

Hunter Maritime Acquisition Corp

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 8.55%</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and slashed the price target from $22 to $20 on May 5, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wells Fargo analyst Michael Sison downgraded the stock from Overweight to Equal-Weight and lowered the price target from $17 to $13 on May 5, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On May 28, Huntsman announced that it has completed the strategic review of its European Maleic Anhydride business.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">latest HUN news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="906" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353.png" alt="" class="wp-image-929655" style="width:634px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353-768x710.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<h3 class="wp-block-heading">FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 5.95%</li>
<li>Keybanc analyst Aleksey Yefremov maintained an Overweight rating and raised the price target from $49 to $53 on May 2, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Seaport Global analyst Michael Harrison maintained a Buy rating and cut the price target from $72 to $55 on March 5, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 30, FMC issued second-quarter adjusted EPS guidance below estimates.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest FMC <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="920" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354.png" alt="" class="wp-image-929656" style="width:604px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354.png 920w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354-768x707.png 768w" sizes="(max-width: 920px) 100vw, 920px" /></a></figure>
<h3 class="wp-block-heading">The Chemours Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 3.30%</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and cut the price target from $22 to $15 on May 12, 2025. This analyst has an accuracy rate of 78%.</li>
<li>Mizuho analyst John Roberts upgraded the stock from Neutral to Outperform with a price target of $19 on March 27, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On May 6, Chemours reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">latest CC news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="908" height="815" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355.png" alt="" class="wp-image-929658" style="width:580px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355-768x689.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45616471/jim-cramer-says-rocket-is-a-very-fine-company-recommends-buying-this-health-care-stock">Jim Cramer Says Rocket Is A &#8216;Very Fine&#8217; Company, Recommends Buying This Health Care Stock</a> </li>
</ul>
Photo via Shutterstock

News

Dividends

Price Target

Pre-Market Outlook

Markets

Trading Ideas

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields

Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) announced today that it has completed the strategic review of its European&nbsp;Maleic Anhydride business. As a result of this review, the Company will close its Maleic Anhydride facility located in Moers, Germany. The closure of the operations at Moers is expected to be complete by the end of the current quarter. In 2024, the European Maleic Anhydride business generated an adjusted EBITDA loss of approximately $10 million. Going forward, the Company intends to serve customers in the European region from its North American facilities located in Pensacola, Florida and Geismar, Louisiana. As a result of the closure of the Moers, Germany facility, Huntsman expects to incur a one-time non-cash asset impairment charge of approximately $75 million during the second quarter of 2025.&nbsp; &nbsp; &nbsp;

Huntsman to Shut Down German Plant After $10M Loss, Takes $75M Hit But Shifts Focus to US Operations

WIIM

AVNT

AXTA

CENX

MATV

MEOH

MTUS

PACK

TANH

TROX

Shares of companies within the broader materials sector are trading higher amid overall market strength after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A decrease of trade tensions could reduce demand uncertainty for materials.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Tronox Holdings plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 9.77%</li>
<li>BMO Capital analyst John McNulty downgraded the stock from Outperform to Market Perform and cut the price target from $13 to $7 on May 7, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and slashed the price target from $12 to $8 on May 5, 2024. This analyst has an accuracy rate of 79%.</li>
<li>Recent News: On April 30, Tronox Holdings posted first-quarter adjusted loss of 15 cents per share.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest TROX <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="908" height="815" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100.png" alt="" class="wp-image-909780" style="width:628px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100-768x689.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 8.32%</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and cut the price target from $22 to $20 on May 5, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wells Fargo analyst Michael Sison downgraded the stock from Overweight to Equal-Weight and slashed the price target from $17 to $13 on May 5, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 1, Huntsman reported in-line loss for the first quarter.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest HUN <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="911" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101.png" alt="" class="wp-image-909782" style="width:559px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101-768x694.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
<h3 class="wp-block-heading">FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.34%</li>
<li>Keybanc analyst Aleksey Yefremov maintained an Overweight rating and raised the price target from $49 to $53 on May 2, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Seaport Global analyst Michael Harrison maintained a Buy rating and cut the price target from $72 to $55 on March 5, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On April 30, FMC issued second-quarter adjusted EPS guidance below estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest FMC <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="912" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102.png" alt="" class="wp-image-909783" style="width:560px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102-768x701.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45285413/top-3-financial-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Financial Stocks Which Could Rescue Your Portfolio This Month</a> </li>
</ul>
Photo via Shutterstock

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks With Over 6% Dividend Yields

Goldman Sachs analyst Duffy Fischer maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Sell and lowers the price target from $19 to $13.5.

Goldman Sachs Maintains Sell on Huntsman, Lowers Price Target to $13.5

RBC Capital analyst Arun Viswanathan maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Sector Perform and lowers the price target from $15 to $12.

RBC Capital Maintains Sector Perform on Huntsman, Lowers Price Target to $12

Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) reported in-line loss for the first quarter, after the <a href="https://www.benzinga.com/quote/HUN/earnings">closing bell on Thursday</a>.
The company posted a quarterly loss of 11 cents per share, which met the analyst consensus estimate. The company reported quarterly sales of $1.41 billion which missed the analyst consensus estimate of $1.49 billion.
Peter R. Huntsman, Chairman, President, and CEO, said, &#8220;Since our last earnings call, short term business conditions continue to change markedly. Low visibility and customer uncertainty regarding demand trends over the coming months are pressuring order patterns in many of our key markets, including construction, transportation, and other industrial related markets. The cautious customer order patterns are muting the seasonal volume improvement our markets typically experience during the second quarter. While we are hopeful that demand conditions improve, we are not waiting for that to happen and remain aggressive on costs which include announced workforce reductions as well as asset optimization in both Europe and North America. We are on-track to complete our review of strategic options for our European maleic anhydride business by this summer, which we will communicate once completed. Protecting the balance sheet remains a priority in addition to focusing on cash generation as we navigate the Company through the current environment.&#8221;
Huntsman shares fell 2.8% to trade at $11.77 on Monday.
These analysts made changes to their price targets on Huntsman following earnings announcement.
<ul>
<li>Morgan Stanley analyst Angel Castillo maintained Huntsman with an Equal-Weight rating and lowered the price target from $20 to $13.5.</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained the stock with an Overweight rating and lowered the price target from $22 to $20.</li>
</ul>
Considering buying HUN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103709/image-39-1024x586.png" alt="" class="wp-image-901591" style="width:633px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103709/image-39-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103709/image-39-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103709/image-39-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/05103709/image-39.png 1105w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45193793/top-3-tech-and-telecom-stocks-that-may-jump-this-quarter">Top 3 Tech And Telecom Stocks That May Jump This Quarter</a> </li>
</ul>
Photo via Shutterstock

Earnings

Huntsman Analysts Cut Their Forecasts Following Q1 Results

JP Morgan analyst Jeffrey Zekauskas maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Overweight and lowers the price target from $22 to $20.

JP Morgan Maintains Overweight on Huntsman, Lowers Price Target to $20

Morgan Stanley analyst Angel Castillo maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Equal-Weight and lowers the price target from $20 to $13.5.

Morgan Stanley Maintains Equal-Weight on Huntsman, Lowers Price Target to $13.5

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Monday.
Shares of Netflix, Inc. (NASDAQ: NFLX fell sharply in today's <a href="https://www.benzinga.com/general/education/25/05/45187710/peter-schiff-says-trumps-100-tariff-on-foreign-films-pointless-without-targeting-streamingwarns-netflix-subscribers-would-bear-cost">pre-market trading</a>.
Economist Peter Schiff criticized President Donald Trump‘s proposed 100% tariff on foreign-produced movies, questioning its implementation and suggesting that Netflix subscribers would ultimately bear the cost.
Netflix shares dipped 4.7% to $1,102.66 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>NetClass Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTCL#NASDAQ">NTCL</a>) shares tumbled 14.6% to $14.94 in pre-market trading.</li>
<li>ManpowerGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) shares dipped 10.4% to $39.71 in pre-market trading after gaining 4% on Friday.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) declined 9.8% to $2.29 in pre-market trading. ImmunityBio received a Refusal to File letter from the FDA for the supplemental biologics license application for ANKTIVA plus Bacillus Calmette-Guerin.</li>
<li>Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) declined 9.4% to $10.98 in today's pre-market trading. Huntsman, last week, reported worse-than-expected first-quarter sales results.</li>
<li>Garrett Motion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NASDAQ">GTX</a>) shares fell 7% to $10.10 in pre-market trading. On Friday, BWS Financial analyst Hamed Khorsand maintained Garrett Motion with a Buy and raised the price target from $12 to $14.</li>
<li>USA Rare Earth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAR#NASDAQ">USAR</a>) fell 5% to $9.80 in pre-market trading. USA Rare Earth recently announced a $75 million PIPE investment.</li>
<li>Guardant Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) fell 5% to $44.50 in pre-market trading after dipping 4% on Friday.</li>
<li>Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) dipped 4.8% to $13.39 in pre-market trading.</li>
<li>CNA Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) fell 2.6% to $47.11 in pre-market trading following downbeat quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45164497/jim-cramer-this-financial-stock-is-a-buy-likes-exlservice-holdings">Jim Cramer: Sunrun Had &#8216;Bad Couple Of Quarters,&#8217; ExlService Holdings Is &#8216;Solid&#8217;</a> </li>
</ul>
Photo via Shutterstock

Movers

IBRX

NFLX

NTCL

UPXI

USAR

Netflix, CNA Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Shares of Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFAI#NASDAQ">FFAI</a>) rose sharply <a href="https://www.benzinga.com/quote/FFAI">in pre-market trading</a>.
Faraday Future&#8217;s FX Brand secured second pre-order with 300 FX Super One MPVs from Sky Horse Auto.
Faraday Future Intelligent Electric shares jumped 6% to $1.24 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>NuCana plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) rose 158% to $1.23 in pre-market trading after falling around 12% on Friday.</li>
<li>AGM Group Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) surged 55.8% to $0.1136 in pre-market trading after dipping around 22% on Friday.</li>
<li>N2OFF, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) gained 41.4% to $0.4001 in pre-market trading after surging 19% on Friday.</li>
<li>SharpLink Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) jumped 23.6% to $0.3860 in pre-market trading. SharpLink Gaming, last week, announced a 1-for-12 reverse stock split.</li>
<li>Quince Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>) gained 21.7% to $1.29 in pre-market trading.</li>
<li>JE Cleantech Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JCSE#NASDAQ">JCSE</a>) surged 18.5% to $1.16 in pre-market trading.</li>
<li>Polyrizon Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) rose 17.9% to $1.19 in pre-market trading after the company announced its planned reverse split will not be effected.</li>
<li>Thumzup Media Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) gained 13.1% to $5.77 in pre-market trading.</li>
<li>ATIF Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) gained 9.3% to $1.00 in pre-market trading after gaining 5% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Impact BioMedical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBO#NYSE">IBO</a>) shares dipped 24.1% to $0.5681 in pre-market trading after jumping 87% on Friday.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares fell 21.8% to $0.4012 in pre-market trading after the company announced a 1-for-28 reverse stock split.</li>
<li>Freight Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) fell 20.7% to $1.65 in pre-market trading. Freight Technologies shares jumped 111% on Friday on continued strength after the company on Thursday announced it entered into an agreement for the issuance of convertible notes through a facility of up to $20 million.</li>
<li>Click Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares fell 19.3% to $0.2773 in pre-market trading after jumping 59% on Friday.</li>
<li>Smart Digital Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDM#NASDAQ">SDM</a>) shares tumbled 16.7% to $5.09 in pre-market trading after jumping 53% on Friday.</li>
<li>Unusual Machines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#NYSE">UMAC</a>) dipped 14.6% to $5.90 in pre-market trading after the company announced a proposed public offering.</li>
<li>Energy Services of America Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESOA#NASDAQ">ESOA</a>) declined 14.3% to $8.09 in pre-market trading after gaining over 4% on Friday.</li>
<li>ManpowerGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) fell 10.4% to $39.71 in pre-market trading after gaining 4% on Friday.</li>
<li>Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) fell 9.4% to $10.98 in today's pre-market trading. Huntsman, last week, reported worse-than-expected first-quarter sales results.</li>
<li>Garrett Motion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NASDAQ">GTX</a>) fell 7% to $10.10 in pre-market trading. On Friday, BWS Financial analyst Hamed Khorsand maintained Garrett Motion with a Buy and raised the price target from $12 to $14.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45164497/jim-cramer-this-financial-stock-is-a-buy-likes-exlservice-holdings">Jim Cramer: Sunrun Had &#8216;Bad Couple Of Quarters,&#8217; ExlService Holdings Is &#8216;Solid&#8217;</a> </li>
</ul>
Photo via Shutterstock

AGMH

CLIK

ESOA

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

FRGT

JCSE

NCNA

NITO

PLRZ

QNCX

RNAZ

SBET

Morgan Stanley Capital-Protected Notes Based on Value of S&P 500 Index

TZUP

UMAC

ZBAI

Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Huntsman shares are trading lower after the company reported worse-than-expected Q1 sales results.

Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 83.33 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $1.41 billion which missed the analyst consensus estimate of $1.49 billion by 5.29 percent. This is a 4.08 percent decrease over sales of $1.47 billion the same period last year.

Earnings Misses

Huntsman Q1 Adj. EPS $(0.11), Inline, Sales $1.41B Miss $1.49B Estimate

AAMI

AAPL

ABNB

ACCO

ADPT

AGCO

AGIO

ALHC

ALKS

ALNY

ALSN

AMGN

AMWL

AMZN

APLE

APTV

ARDX

ARVN

ASND

ASPS

ASUR

ATEC

ATEN

AXTI

BBAI

BIIB

BJRI

BLDR

BMRN

BOOM

BPMC

BRFH

CABO

CARR

CART

CERS

CMLS

COHN

COHU

COLM

COMM

COOK

CRAI

CTRE

CUBE

CWST

DBRG

DINO

DSGR

DUOL

DXCM

ECVT

ELME

Earnings Scheduled For May 1, 2025

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)</h3>
<ul>
<li>Dividend Yield: 9.66%</li>
<li>Wells Fargo analyst Michael Sison maintained an Overweight rating and cut the price target from $40 to $35 on April 9, 2025. This analyst has an accuracy rate of 65%.</li>
<li>JP Morgan analyst Jeffrey Zekauskas downgraded the stock from Overweight to Neutral and cut the price target from $40 to $31 on April 4, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: Dow posted better-than-expected first-quarter results on Thursday.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest DOW <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0424">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0424"><img loading="lazy" decoding="async" width="913" height="821" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062048/image-148.png" alt="" class="wp-image-886183" style="width:498px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062048/image-148.png 913w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062048/image-148-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062048/image-148-768x691.png 768w" sizes="(max-width: 913px) 100vw, 913px" /></a></figure>
<h3 class="wp-block-heading">The Chemours Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>)</h3>
<ul>
<li>Dividend Yield: 8.45%</li>
<li>Mizuho analyst John Roberts upgraded the stock from Neutral to Outperform with a price target of $19 on March 27, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and slashed the price target from $25 to $22 on Jan. 13, 2025. This analyst has an accuracy rate of 78%.</li>
<li>Recent News: Chemours Company will issue its first quarter financial results after the closing bell on Tuesday, May 6.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest CC <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0424">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0424"><img loading="lazy" decoding="async" width="902" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062208/image-149.png" alt="" class="wp-image-886190" style="width:551px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062208/image-149.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062208/image-149-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062208/image-149-768x700.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul>
<li>Dividend Yield: 7.75%</li>
<li>Wells Fargo analyst Michael Sison maintained an Overweight rating and cut the price target from $20 to $17 on April 9, 2025. This analyst has an accuracy rate of 65%.</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and cut the price target from $25 to $22 on Feb. 19, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: Huntsman will hold a conference call on Friday, May 2, to discuss its first quarter financial results.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0424">HUN news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0424"><img loading="lazy" decoding="async" width="907" height="810" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062307/image-150.png" alt="" class="wp-image-886192" style="width:551px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062307/image-150.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062307/image-150-300x268.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/24062307/image-150-768x686.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44948767/top-2-consumer-stocks-that-may-implode-this-month">Top 2 Consumer Stocks That May Implode This Month</a> </li>
</ul>
Photo via Shutterstock

Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 7% Dividend Yields

Throughout the last three months, 9 analysts have evaluated Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $17.78, along with a high estimate of $22.00 and a low estimate of $13.00. A 15.77% drop is evident in the current average compared to the previous average price target of $21.11. 
<img src="https://www.benzinga.com/files/images/story/2025/1744754420_0_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Huntsman. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Steve Byrne &#x7C;B of A Securities &#x7C;Lowers &#x7C;Neutral &#x7C; $15.00&#x7C;$22.00 &#x7C; 
&#x7C;Michael Sison &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $17.00&#x7C;$20.00 &#x7C; 
&#x7C;Joshua Spector &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $13.00&#x7C;$18.00 &#x7C; 
&#x7C;Patrick Cunningham &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $14.00&#x7C;$19.00 &#x7C; 
&#x7C;Michael Sison &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $20.00&#x7C;$22.00 &#x7C; 
&#x7C;Duffy Fischer &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Sell &#x7C; $19.00&#x7C;$22.00 &#x7C; 
&#x7C;Arun Viswanathan &#x7C;RBC Capital &#x7C;Raises &#x7C;Sector Perform &#x7C; $18.00&#x7C;$17.00 &#x7C; 
&#x7C;Jeffrey Zekauskas &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $22.00&#x7C;$25.00 &#x7C; 
&#x7C;Michael Sison &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $22.00&#x7C;$25.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Huntsman. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Huntsman compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Huntsman's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Huntsman's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HUN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Huntsman analyst ratings.</a>
<h2>Delving into Huntsman's Background</h2>
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States &amp; Canada, Europe, Asia-Pacific, and the Rest of the world.
<h3>Unraveling the Financial Story of Huntsman</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3M period, Huntsman showcased positive performance, achieving a revenue growth rate of 3.49% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Huntsman's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -9.71%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Huntsman's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -4.64%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Huntsman's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -1.95%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.76, Huntsman adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 9 Analysts Discuss Huntsman Stock

B of A Securities analyst Steve Byrne downgrades Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) from Buy to Neutral and lowers the price target from $22 to $15.

Downgrades

B of A Securities Downgrades Huntsman to Neutral, Lowers Price Target to $15

Shares of companies in the broader chemicals sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

Wells Fargo analyst Michael Sison maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Overweight and lowers the price target from $20 to $17.

Wells Fargo Maintains Overweight on Huntsman, Lowers Price Target to $17

UBS analyst Joshua Spector maintains Huntsman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>) with a Neutral and lowers the price target from $18 to $13.

UBS Maintains Neutral on Huntsman, Lowers Price Target to $13

Commodities

Press Releases

Huntsman Announces Fourth Quarter 2024 Common Dividend

Huntsman to Discuss Fourth Quarter 2024 Results on February 18, 2025

Huntsman Announces Fourth Quarter 2024 Earnings

Huntsman Announces First Quarter 2025 Common Dividend and 2025 Annual Meeting of Stockholders

Huntsman to Discuss First Quarter 2025 Results on May 2, 2025

Huntsman Corporation Announces New Purification and Packaging Capability through its E-GRADE® Unit in Conroe, Texas

Huntsman Announces First Quarter 2025 Earnings

Huntsman Announces Second Quarter 2025 Common Dividend

Huntsman Announces Officer Changes: Tony Hankins to Retire and Steen Weien Hansen Named Division President, Huntsman Polyurethanes

Huntsman Completes European Maleic Anhydride Strategic Review

Ashland

AdvanSix

Avient

Braskem

Cabot

Chemours

Ecovyst

H.B. Fuller

Hawkins

Innospec

Kronos Worldwide

Quaker Houghton

Minerals Technologies

Ingevity

Olin

PureCycle Technologies, Inc. - Common stock

PureCycle Technologies

Perimeter Solutions

Stepan

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

Sasol

Sensient Technologies Corporation Common Stock

Sensient Technologies

Tronox Holdings

CVR Partners, LP Common Units representing Limited Partner Interests

CVR Partners

Westlake Chemical Partners LP Common Units representing limited partner interests

Comments

Huntsman

ニュース

パートナーシップ

ベンジンガ・グローバル